Clorox (CLX) FY2011 results: revenue $5.2 billion, down 0.1% on the year
Clorox Co. (CLX) reported revenue of $5.2 billion for fiscal 2011, the year ended 30 June 2011, down 0.1% on the year before. Net income was $557 million, down 7.6%, and diluted earnings per share $4.02. The figures are the company's own, from the 10-K it filed with the SEC on 24 August 2012.
Revenue
$5.2 billion
-0.1% on the year
FY2008FY2011
Operating margin
n/a
FY2008FY2011
Net income
$557 million
-7.6% on the year
FY2008FY2011
Diluted EPS
$4.02
-5.2% on the year
FY2008FY2011
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2011
FY2010
FY2009
On the year
Last 8 years
Revenue
5,231
5,234
5,158
-0.1%
Cost of revenue
2,958
2,915
2,954
+1.5%
Gross profit
2,273
2,319
2,204
-2.0%
Gross margin
43.5%
44.3%
42.7%
Research and development
115
118
113
-2.5%
Selling, general and administrative
735
734
703
+0.1%
Interest expense
123
139
161
-11.5%
Income tax
276
322
274
-14.3%
Net income
557
603
537
-7.6%
Net margin
10.6%
11.5%
10.4%
Diluted EPS
$4.02
$4.24
$3.79
-5.2%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2011
FY2010
FY2009
On the year
Last 8 years
Operating cash flow
698
819
738
-14.8%
Capital expenditure
228
201
196
+13.4%
Free cash flow
470
618
542
-23.9%
Free cash flow margin
9.0%
11.8%
10.5%
Cash from investing
544
-231
-197
Cash from financing
-1,078
-706
-540
Depreciation and amortisation
173
183
188
-5.5%
Share-based compensation
32.0
60.0
58.0
-46.7%
Buybacks
655
150
n/a
+336.7%
Dividends paid
303
282
258
+7.4%
Dividend per share
$2.25
$2.05
$1.88
+9.8%
Diluted shares, weighted
138m
142m
140m
-2.4%
Shares outstanding at period end
131m
139m
139m
-5.5%
Balance sheet
$ million
FY2011
FY2010
FY2009
On the year
Last 8 years
Shareholders' equity
-86.0
83.0
-175
Debt
2,584
2,795
2,728
-7.5%
Other liabilities
1,665
1,677
2,023
-0.7%
Total liabilities and equity
4,163
4,555
4,576
-8.6%
Fixed assets
1,039
966
941
+7.6%
Goodwill
1,070
1,303
1,284
-17.9%
Cash and equivalents
259
87.0
206
+197.7%
Receivables
525
540
486
-2.8%
Inventory
382
332
366
+15.1%
Other assets
888
1,327
1,293
-33.1%
Total assets
4,163
4,555
4,576
-8.6%
10-K for the year ended 30 June 2011, filed 24 August 2012: the filing.